Developing World Class
RNA Therapeutic Technologies

About Us

eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics. Our platforms include mRNA construct design and optimization, proprietary lipid nanoparticles (LNP) and formulations, and in-house process engineering capabilities for mRNA drug substance manufacturing.

// OUR COMPANY

What We Do

Immunotherapies

Immunotherapies

Contract Manufacturing

Contract Manufacturing
// Stay up to date

Newsroom

// 05 April 2022

eTheRNA Announces Relocation and Expansion of R&D Facility

GENT, BELGIUM, April 5, 2022 – eTheRNA immunotherapies NV (“eTheRNA”), an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium.

// Our company

Come Join Us

Visit our careers site.

WE'D LIKE TO HEAR FROM YOU

eTheRNA engineering RNA_white
Europe
Europe

Corporate Headquarters — Galileilaan 19, 2845 Niel, Belgium

Europe
Europe

Discovery Facility — Frieda Saeystraat 1B, 3rd floor, 9052 Zwijnaarde - Gent, Belgium

North America
North America

530 7th Avenue — Suite 902, New York, NY 10018 United States

Asia-Pacific
Asia-Pacific

Unit 605-07, 6/F Wing on Center, 111 Connaught Road Central, Sheung Wan, Hong Kong

info@etherna.be

Our Mailbox

+32 3 369 17 40

Our Phone

© 2022 eTheRNA | Studio Hanswijk